Nixipin-T Injection combines Cefepime with Tazobactam, synergizing their antibacterial properties to combat severe infections. Cefepime, a fourth-generation cephalosporin, offers broad-spectrum coverage against gram-positive and gram-negative bacteria. Tazobactam inhibits beta-lactamase enzymes, extending Cefepime's activity against resistant strains. Administered intravenously, Nixipin-T Injection is vital in hospital settings for treating complicated infections where multidrug resistance is a concern. It provides reliable therapy, ensuring effective treatment and favorable outcomes in critical care scenarios.Available in PCD Franchise for injectable range and third party manufacturing.